JP2023011759A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023011759A5 JP2023011759A5 JP2022172687A JP2022172687A JP2023011759A5 JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5 JP 2022172687 A JP2022172687 A JP 2022172687A JP 2022172687 A JP2022172687 A JP 2022172687A JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026044825A JP2026102816A (ja) | 2020-07-22 | 2026-03-18 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022538564A JPWO2022018875A1 (cg-RX-API-DMAC7.html) | 2020-07-22 | 2020-07-22 | |
| PCT/JP2020/028575 WO2022018875A1 (ja) | 2020-07-22 | 2020-07-22 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
| JP2022538564 | 2020-07-22 | ||
| JP2021121960A JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021121960A Division JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026044825A Division JP2026102816A (ja) | 2020-07-22 | 2026-03-18 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023011759A JP2023011759A (ja) | 2023-01-24 |
| JP2023011759A5 true JP2023011759A5 (cg-RX-API-DMAC7.html) | 2024-08-07 |
Family
ID=79729374
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538564A Pending JPWO2022018875A1 (cg-RX-API-DMAC7.html) | 2020-07-22 | 2020-07-22 | |
| JP2021121960A Active JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
| JP2022172687A Ceased JP2023011759A (ja) | 2020-07-22 | 2022-10-27 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
| JP2026044825A Pending JP2026102816A (ja) | 2020-07-22 | 2026-03-18 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538564A Pending JPWO2022018875A1 (cg-RX-API-DMAC7.html) | 2020-07-22 | 2020-07-22 | |
| JP2021121960A Active JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026044825A Pending JP2026102816A (ja) | 2020-07-22 | 2026-03-18 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Country Status (3)
| Country | Link |
|---|---|
| JP (4) | JPWO2022018875A1 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102550455B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022018875A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115151533B (zh) | 2020-01-10 | 2025-08-08 | 医疗免疫工程公司 | Mek抑制剂及其治疗用途 |
| AU2022312992A1 (en) * | 2021-07-21 | 2024-02-29 | Chugai Seiyaku Kabushiki Kaisha | Method for producing arylamide derivative |
| WO2023204259A1 (ja) * | 2022-04-20 | 2023-10-26 | 中外製薬株式会社 | がんの治療又は予防用医薬 |
| EP4551558A2 (en) * | 2022-07-08 | 2025-05-14 | Nested Therapeutics, Inc. | Mitogen-activated protein kinase (mek) inhibitors |
| JP2026522033A (ja) * | 2023-07-06 | 2026-07-03 | 華健未来(成都)科技股▲フン▼有限公司 | 芳香族アミド誘導体およびその使用 |
| WO2025063275A1 (ja) * | 2023-09-21 | 2025-03-27 | 中外製薬株式会社 | アリールアミド誘導体の製造方法 |
| AU2024417154A1 (en) * | 2024-01-01 | 2026-08-13 | Huajian Future (Chengdu) Technology Co., Ltd. | Aromatic hydrazide derivative and medical use thereof |
| WO2026098657A1 (zh) * | 2024-11-08 | 2026-05-15 | 先声再明医药股份有限公司 | 作为mek抑制剂的杂环化合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4931419B2 (ja) * | 2003-09-19 | 2012-05-16 | 中外製薬株式会社 | 新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用 |
| KR101190912B1 (ko) * | 2003-11-19 | 2012-10-12 | 어레이 바이오파마 인크. | Mek의 헤테로시클릭 억제제 및 그의 사용 방법 |
| MY144232A (en) * | 2004-07-26 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | 5-substituted-2-phenylamino benzamides as mek inhibitors |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| WO2012020742A1 (ja) * | 2010-08-10 | 2012-02-16 | 塩野義製薬株式会社 | 新規複素環誘導体およびそれらを含有する医薬組成物 |
| US20130123255A1 (en) * | 2011-11-10 | 2013-05-16 | Chugai Seiyaku Kabushiki Kaisha | Combination of a pi3k inhibitor and a mek inhibitor |
| JP2016034900A (ja) * | 2012-11-26 | 2016-03-17 | 中外製薬株式会社 | 5−置換−2−フェニルアミノ−ベンズアミド類の製造方法 |
| CN109988105A (zh) * | 2014-01-27 | 2019-07-09 | 天津滨江药物研发有限公司 | 作为蛋白激酶抑制剂的氮杂环类化合物及其制备方法 |
| CN105384738B (zh) * | 2014-08-21 | 2017-08-29 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途 |
| AR121078A1 (es) * | 2020-01-22 | 2022-04-13 | Chugai Pharmaceutical Co Ltd | Derivados de arilamida con actividad antitumoral |
| KR20230122174A (ko) * | 2020-07-22 | 2023-08-22 | 추가이 세이야쿠 가부시키가이샤 | 아릴 아마이드 유도체를 포함하는 조성물 |
-
2020
- 2020-07-22 WO PCT/JP2020/028575 patent/WO2022018875A1/ja not_active Ceased
- 2020-07-22 JP JP2022538564A patent/JPWO2022018875A1/ja active Pending
-
2021
- 2021-07-21 KR KR1020210095267A patent/KR102550455B1/ko active Active
- 2021-07-26 JP JP2021121960A patent/JP7168734B2/ja active Active
-
2022
- 2022-10-27 JP JP2022172687A patent/JP2023011759A/ja not_active Ceased
-
2023
- 2023-06-26 KR KR1020230081877A patent/KR20230098762A9/ko active Pending
-
2026
- 2026-03-18 JP JP2026044825A patent/JP2026102816A/ja active Pending